Skylands Capital LLC increased its stake in shares of The Joint Corp. (NASDAQ:JYNT - Free Report) by 10.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 738,728 shares of the company's stock after purchasing an additional 72,700 shares during the period. Joint makes up approximately 1.1% of Skylands Capital LLC's investment portfolio, making the stock its 24th largest position. Skylands Capital LLC owned 4.93% of Joint worth $7,853,000 at the end of the most recent reporting period.
Several other institutional investors have also recently added to or reduced their stakes in the stock. FMR LLC grew its position in Joint by 38.0% in the 3rd quarter. FMR LLC now owns 10,787 shares of the company's stock valued at $123,000 after acquiring an additional 2,971 shares in the last quarter. Franklin Resources Inc. purchased a new position in shares of Joint in the third quarter valued at approximately $175,000. Sanders Morris Harris LLC acquired a new position in shares of Joint in the fourth quarter valued at approximately $228,000. BNP Paribas Financial Markets increased its stake in Joint by 5.4% during the 3rd quarter. BNP Paribas Financial Markets now owns 22,510 shares of the company's stock worth $258,000 after buying an additional 1,156 shares during the period. Finally, Barclays PLC lifted its holdings in Joint by 71.4% during the 3rd quarter. Barclays PLC now owns 25,609 shares of the company's stock worth $294,000 after buying an additional 10,671 shares in the last quarter. Institutional investors and hedge funds own 76.88% of the company's stock.
Analysts Set New Price Targets
Several equities analysts have commented on the stock. StockNews.com upgraded shares of Joint from a "hold" rating to a "buy" rating in a research note on Friday, November 15th. Roth Mkm reduced their price target on Joint from $16.00 to $15.00 and set a "buy" rating on the stock in a research report on Friday, November 8th.
View Our Latest Research Report on JYNT
Joint Price Performance
Shares of JYNT traded down $0.09 during midday trading on Thursday, reaching $11.41. The stock had a trading volume of 17,192 shares, compared to its average volume of 33,010. The company's fifty day simple moving average is $10.92 and its two-hundred day simple moving average is $11.19. The company has a market cap of $170.98 million, a price-to-earnings ratio of -10.01 and a beta of 1.60. The Joint Corp. has a 1-year low of $9.10 and a 1-year high of $17.82.
Joint Company Profile
(
Free Report)
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
See Also
Before you consider Joint, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Joint wasn't on the list.
While Joint currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
